RABIHIR-L Capsules

RABIHIR-L is an advanced, dual-action prescription gastrointestinal medication formulated to manage severe acidity, gastroesophageal reflux disease (GERD), and associated intestinal motility disorders. By combining a rapid acid-inhibiting proton pump inhibitor with a sustained-release prokinetic agent, it effectively stops acid reflux while optimizing the digestive tract’s natural flow.

Key Features & Benefits

• Targeted Enteric Coating: The Rabeprazole granules are enteric-coated to bypass the harsh environment of the stomach, dissolving safely in the intestine for maximum structural absorption and targeted acid control.

• Sustained-Release Motility: Formulated with Levosulpiride in a sustained-release form, ensuring a steady, long-lasting release that prevents nausea, bloating, and food regurgitation throughout the day.

• Complete Reflux Defense: Actively accelerates gastric emptying and tones the lower esophageal sphincter, preventing stomach contents from traveling upward into the throat.

• Standard Clinical Configuration: Available in a standard $10 \times 10$ capsules pack, ensuring a reliable, long-term supply for chronic therapeutic care.